FRIDAY, Oct. 20, 2017 (HealthDay News) — Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a brand new study suggests.
Hepatitis B virus attacks the liver in addition to can cause cirrhosis in addition to liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, although there can be little clinical evidence on whether regular aspirin use can prevent liver cancer in people with hepatitis B.
Researchers by Taiwan analyzed data by close to 205,000 patients with chronic hepatitis B. They found of which those on daily aspirin were much less likely to develop liver cancer over several years than those who did not take aspirin.
of which’s important to note, however, of which the study only found these associations, although did not establish a cause-in addition to-effect link.
The findings are scheduled to be presented Monday at an American Association for the Study of Liver Diseases meeting, in Washington, D.C.
About 240 million people worldwide have chronic hepatitis B, according to the association.
While antiviral medicines can significantly reduce liver cancer risk in people with the hepatitis B virus (HBV), they don’t eliminate of which in addition to are not appropriate for everyone, said lead investigator Dr. Teng-Yu Lee.
Lee can be a researcher inside the department of gastroenterology at Taichung Veterans General Hospital.
“For effectively preventing HBV-related liver cancer, the findings of of which study may help hepatologists treat patients with chronic HBV infection inside the future, particularly for those who are not indicated for antiviral therapy. We are pursuing prospective investigations for further confirming the findings,” Lee said in a meeting news Discharge.
Research presented at medical meetings can be typically considered preliminary until published in a peer-reviewed journal.
— Robert Preidt
Copyright © 2017 HealthDay. All rights reserved.
SOURCE: American Association for the Study of Liver Diseases, news Discharge, Oct. 20, 2017
Subscribe to MedicineNet’s General Health Newsletter